GeneFerm Biotechnology Co Ltd (1796) — Free Cash Flow Generation Index
GeneFerm Biotechnology Co Ltd (1796) has a Free Cash Flow Generation Index of -3.13x as of June 2025. Free cash flow of NT$-4.53 Million represents -3% of operating cash flow (NT$1.45 Million). Read GeneFerm Biotechnology Co Ltd (1796) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GeneFerm Biotechnology Co Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for GeneFerm Biotechnology Co Ltd across 8 annual periods. Explore capital reinvestment ratio of GeneFerm Biotechnology Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for GeneFerm Biotechnology Co Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for GeneFerm Biotechnology Co Ltd. For the full company profile including market capitalisation, see 1796 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.81x | NT$-14.61 Million | NT$8.09 Million | NT$22.70 Million | ▼ -389.0% |
| 2023 | 0.62x | NT$118.91 Million | NT$190.31 Million | NT$71.40 Million | ▲ +149.0% |
| 2022 | -1.27x | NT$-155.98 Million | NT$122.43 Million | NT$278.42 Million | ▼ -328.4% |
| 2021 | -0.30x | NT$-33.37 Million | NT$112.23 Million | NT$145.61 Million | ▲ +35.2% |
| 2020 | -0.46x | NT$-25.90 Million | NT$56.42 Million | NT$82.32 Million | ▲ +83.1% |
| 2019 | -2.72x | NT$-39.89 Million | NT$14.69 Million | NT$54.57 Million | ▼ -995.1% |
| 2018 | 0.30x | NT$12.78 Million | NT$42.14 Million | NT$28.81 Million | ▲ +269.2% |
| 2017 | 0.08x | NT$5.02 Million | NT$61.08 Million | NT$55.16 Million | — |